Tim Coughlin
Vermögen: 3 Mio $ am 30.09.2026
Vermögen: 3 Mio $ am 30.09.2026
Mr. Timothy P.
Coughlin, CPA, is a Chairman at aTyr Pharma, Inc. and an Independent Director at Travere Therapeutics, Inc. He is on the Board of Directors at Vir Biotechnology, Inc., ADC Therapeutics SA and Travere Therapeutics, Inc. Mr. Coughlin was previously employed as an Independent Director by Fate Therapeutics, Inc., a Chief Financial Officer by Neurocrine Biosciences, Inc., a Vice President-Financial Services by Catholic Health Initiatives, and a Senior Manager-Health Sciences Practice by Ernst & Young LLP.
He also served on the board at Peloton Therapeutics, Inc. He received his undergraduate degree from Temple University (Pennsylvania) and a graduate degree from San Diego State University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 12.06.2026 | 56 250 ( 0,06 % ) | 3 Mio $ | 30.09.2026 | |
ADC THERAPEUTICS LTD 0,06 % | 03.06.2026 | 72 400 ( 0,06 % ) | 88 328 $ | 30.09.2026 |
ATYR PHARMA, INC. 0,06 % | 27.08.2026 | 56 000 ( 0,06 % ) | 16 968 $ | 30.09.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| TRAVERE THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 31.03.2015 |
| ATYR PHARMA, INC. | Vorsitzender | 14.03.2024 |
| ADC THERAPEUTICS SA | Direktor/Vorstandsmitglied | 01.06.2025 |
| VIR BIOTECHNOLOGY, INC. | Direktor/Vorstandsmitglied | 09.06.2026 |
| Unternehmen | Position | Ende |
|---|---|---|
| FATE THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 29.05.2025 |
| PELOTON THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.12.2019 |
CommonSpirit Health (Illinois)
CommonSpirit Health (Illinois) Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit catholic health organization | Finanzdirektor/CFO | 01.01.2002 |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Corporate Officer/Principal | 01.01.1999 |
| NEUROCRINE BIOSCIENCES, INC. | Finanzdirektor/CFO | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 11 |
|---|---|
Neurocrine Biosciences, Inc.
Neurocrine Biosciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes treatments for neurological, neuroendocrine and neuropsychiatric disorders | Health Technology |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
aTyr Pharma, Inc.
aTyr Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a bio therapeutics company that discovers and develops medicines based on novel biological pathways | Health Technology |
Peloton Therapeutics, Inc.
Peloton Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which engages in developing and researching drugs for cancer patients | Health Technology |
CommonSpirit Health (Illinois)
CommonSpirit Health (Illinois) Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit catholic health organization | Commercial Services |
San Diego State University
San Diego State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Temple University (Pennsylvania)
Temple University (Pennsylvania) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fate Therapeutics, Inc.
Fate Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
ADC Therapeutics SA
ADC Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops proprietary antibody drug conjugates for the treatment of both solid and hematological cancers | Health Technology |
Travere Therapeutics, Inc.
Travere Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in developing and delivering life-changing therapies to people living with rare kidney, liver & metabolic diseases | Health Technology |
Vir Biotechnology, Inc.
Vir Biotechnology, Inc. BiotechnologyHealth Technology Develops cures and treatments drug for viral & bacterial diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen